title: Side effects of treatment with antimony salts.
authors.affiliation: Department of Internal Medicine, Unversity of Palermo, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Malta
authors.forename: M
authors.initials: M
authors.lastname: Affronti
authors.forename: S
authors.initials: S
authors.lastname: Di Rosa
authors.forename: L
authors.initials: L
authors.lastname: Vassallo
authors.forename: M
authors.initials: M
authors.lastname: Renda
authors.forename: G
authors.initials: G
authors.lastname: Trifirò
authors.forename: M E
authors.initials: ME
authors.lastname: Rubino
authors.forename: G B
authors.initials: GB
authors.lastname: Rini
mesh_terms: D000981:Antiprotozoal Agents / Q000009:adverse effects; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D006529:Hepatomegaly / Q000139:chemically induced; D006801:Humans; D007008:Hypokalemia / Q000139:chemically induced; D007898:Leishmaniasis, Visceral / Q000188:drug therapy*; D008536:Meglumine / Q000009:adverse effects*; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000009:adverse effects*; D013163:Splenomegaly / Q000139:chemically induced
chemical_list: D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate